Healthcare Startup, Ceklab, Targeted 8 Million Laboratory Examinations

Healthcare startup, Ceklab, aimed to help the Indonesian people carry out eight million laboratory examinations in the next five years. As revealed by Ceklab’s Founder and CEO Caesar Givani, now Ceklab has assisted 1,930 Indonesians in conducting 10,550 laboratory examinations. Ceklab itself is a health startup fostered by the NextDev.

Ceklab currently operates in 13 areas in Indonesia including cities in Java, Kalimantan, Sumatra, Sulawesi, and West Nusa Tenggara. “The highest diseases that burden the Indonesian people financially and in life expectancy are almost all chronic diseases such as heart disease, stroke, kidney failure, etc,” Caesar said.

He continued that those diseases are not a sudden occurrence. For this reason, one way to find out if there are symptoms is by laboratory tests. “Ceklab’s vision is to invite as many Indonesians as possible to prevent chronic diseases through prevention, in this case, a laboratory examination,” he added.

Caesar himself is a resident doctor at Dr. Soetomo Surabaya. Unfortunately, Caesar said, when inviting people to do a laboratory check, there are some problems. Most of the problems are related to the different costs in each clinic and not all are covered by the BPJS (Indonesian health insurance).

Ceklab’s Goal to Help People Avoid Chronic Diseases

“Many labs are not covered by BPJS. This is an everyday problem. Then, there is a demand for home service which is increasing due to busyness and old age. Not to mention, the reading of lab results that need guidance. This is why we build Ceklab,” Caesar said.

The goal is to help people avoid chronic diseases through affordable laboratory examinations, free reading of lab results, and the convenience of accessing lab results history anytime and anywhere through the application. Ceklab also had other targets in the next few years.

Not only targeting five million lab examinations, but this startup also plans to target funding from investors who have the same vision in 2020. “We’re on track so far. At least, in the next six months, we will try to add 5,000 lab examinations to help the lab check community.”

Caesar continued: “Then in the next five years, we are targeting eight million lab examinations.” Besides The NextDev, Ceklab which is also incubated by IDX incubator also has a target to become a public company through an Initial Public Offering (IPO).

“The next target can be an IPO. It can be between 2020 and 2024. It’s a target, but still we need to adjust to the time,” he said. For the IPO, Caesar said that he wanted the startup to get bigger in the market.

Ceklab Planned to Scale Up in 2020

“We have a plan to scale up in 2020,” Caesar said. Concerning the funding plan, Caesar claimed that Ceklab currently still uses its capital. “We are bootstrapping. We purely use our funds, but we continue to profit. If you want a quick breakthrough, you need resources and investment.”

However, Ceklab does not want to carelessly look for investors. In 2020, he hoped to get an investor partner who has a shared vision. “We are not just after money. But, we must also understand that as a social entrepreneur, we want something that produces social impact,” he said.

Caesar claimed that there are already offers. However, if it is not suitable his company will not take it.  To attract interest, Ceklab is different from similar applications. Here, users can choose the type of laboratory examination services desired. This is no longer a package.

Similar services are usually available for IDR 1.5 million per package. Meanwhile, Ceklab can offer a rate of IDR 300,000 to 500,000 per inspection. Ceklab itself can be accessed via the Playstore application on Android or through its official website.